COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

B Bikdeli, MV Madhavan, D Jimenez, T Chuich… - Journal of the American …, 2020 - jacc.org
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …

F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

[HTML][HTML] COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

MM Mafham, E Spata, R Goldacre, D Gair, P Curnow… - The Lancet, 2020 - thelancet.com
Background Several countries affected by the COVID-19 pandemic have reported a
substantial drop in the number of patients attending the emergency department with acute …

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

S De Rosa, C Spaccarotella, C Basso… - European heart …, 2020 - academic.oup.com
Aims To evaluate the impact of the COVID-19 pandemic on patient admissions to Italian
cardiac care units (CCUs). Methods and Results We conducted a multicentre, observational …

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary …

J Knuuti, W Wijns, A Saraste, D Capodanno… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open …

M Gimbel, K Qaderdan, L Willemsen, R Hermanides… - The Lancet, 2020 - thelancet.com
Background Current guidelines recommend potent platelet inhibition with ticagrelor or
prasugrel in patients after an acute coronary syndrome. However, data about optimal …

JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease

R Fukazawa, J Kobayashi, M Ayusawa… - Circulation …, 2020 - jstage.jst.go.jp
More than 50 years have passed since Kawasaki disease (KD) was first reported. 1
According to a nationwide survey, the number of patients with KD who became adults was …

JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease

M Nakamura, K Kimura, T Kimura, M Ishihara… - Circulation …, 2020 - jstage.jst.go.jp
In 2019, the Japanese Circulation Society published 2 guidelines in the field of coronary
artery disease (CAD):(1) a guideline for acute coronary syndrome (ACS) that integrated …

Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review

JG Chiabrando, A Bonaventura, A Vecchié… - Journal of the American …, 2020 - jacc.org
Pericarditis refers to the inflammation of the pericardial layers, resulting from a variety of
stimuli triggering a stereotyped immune response, and characterized by chest pain …

Cardiac complications in patients hospitalised with COVID-19

M Linschoten, S Peters, M van Smeden… - … Heart Journal: Acute …, 2020 - academic.oup.com
Aims: To determine the frequency and pattern of cardiac complications in patients
hospitalised with coronavirus disease (COVID-19). Methods and results: CAPACITY-COVID …